Bronstein, Gewirtz & Grossman Announces Regeneron Pharmaceuticals, Inc. Investors Suffering Big Losses Have Opportunity to File Class Action Lawsuit Investing.com

New York, New York–(Newsfile Corp. – January 19, 2025) – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, informs investors that a lawsuit has been filed against Regeneron (NASDAQ:) Pharmaceuticals, Inc. (“Regeneron” or “The Company”) (NASDAQ: REGN) and some of its officers.

Class Description

This lawsuit seeks to recover damages against the Defendants for breach of federal securities laws on behalf of all individuals and entities that purchased or otherwise received Regeneron securities between November 2, 2023 and October 30, 2024, both days inclusive (the “Class Period” ). Such investors are encouraged to participate in this case by visiting the firm’s website: bgandg.com/REGN.

Details of the Case

The complaint alleges that throughout the Class Period, the Defendants lied about possible violations of the False Claims Act by failing to report millions of dollars in rebates given to drug dealers through paying credit card fees.

What’s Next?

A class action lawsuit has been filed. If you wish to review a copy of the Complaint, you may visit the firm’s website: bgandg.com/REGN, or you may contact Peretz Bronstein, Esq. or Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you lost to Regeneron, you have until March 10, 2025, to ask the Court to appoint you as the lead plaintiff. Your ability to participate in any recovery does not require you to act as the primary plaintiff.

No Cost To You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to pay us out-of-pocket costs and attorneys’ fees, usually as a percentage of the total recovery, if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in fraud actions and shareholder forfeiture suits. Our firm has secured hundreds of millions of dollars for investors across the country.

Follow us for updates on LinkedIn, X, Facebook (NASDAQ:), or Instagram.

Advertising attorney. Early results do not guarantee similar results.

To view the source version of this release, please visit https://www.newsfilecorp.com/release/236512